Targeting systemic inflammation in atherosclerosis: Who will benefit?
Eur J Prev Cardiol
.
2018 Jun;25(9):921-922.
doi: 10.1177/2047487318774654.
Epub 2018 May 3.
Authors
Elin Good
1
2
3
,
Ebo de Muinck
1
2
3
Affiliations
1
1 Division of Cardiovascular Medicine, Department of Medical and Health Sciences, Linköping University, Sweden.
2
2 Centre for Medical Image Science and Visualization (CMIV), Linköping University, Sweden.
3
3 Department of Cardiology, Linköping University, Sweden.
PMID:
29719965
DOI:
10.1177/2047487318774654
No abstract available
Publication types
Editorial
Comment
MeSH terms
Atherosclerosis*
C-Reactive Protein
Coronary Disease*
Humans
Inflammation
Prevalence
Substances
C-Reactive Protein